Clinical outcomes and alternative chemotherapy (CT) options in patients (pts) with de novo carboplatin (carbo)-resistant stage III or IV ovarian cancer (CA) based on the drug-induced apoptosis (MiCK) assay. Meeting Abstract

International Collaboration

cited authors

  • Burrell, Matthew O.; Stany, Michael; Rutledge, James; Salom, Emery Manuel; Penalver, Manuel; Hallquist, Allan; Presant, Cary A.

publication date

  • 2013

published in


  • 31


  • 15

research area

  • Oncology  Web of Science Research Area